Interaction of Tomudex with radiation in vitro and in vivo

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 437-442

  Teicher, Beverly A ^a,b   Ara, Gulshan ^a   Chen, Ying Nan ^a   Recht, Abram ^a   Coleman, C Norman ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Colon carcinoma cells; Head and neck squamous carcinoma cells; Thymidylate synthase inhibitor; Tomudex

Indexed keywords

FLUOROURACIL; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL HYPOXIA; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

EID: 0031858463     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.3.437     Document Type: Article

References (17)

1. Touroutoglou N and Pazdur R: Thymidylate synthase inhibitors. Clin Res 2: 227-243, 1996.
2. Jackrnan AL, Farrugia DC, Gibson W, et al: ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer 31A: 1277-1282, 1995.
3. Gibson W, Bisset GMF, Marsham PR, et al: The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cells. Biochem Pharmacol 45: 863-869,1993.
4. Ward WHJ, Kimbell R, Jackman AL: Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase. Biochem Pharmacol 43: 2029-2031, 1992.
5. Vermund H, Hodgett J and Ansfield FJ: Effects of combined irradiation and chemotherapy on transplanted tumors in mice. Am J Roentgenol 85: 559-564, 1961.
6. Vietta T, Eggerding F and Valeriote F: Combined effect of x-radiation and 5-fluorouracil on survival of transplanted leukemic cells. J Natl Cancer Inst 47: 865-870, 1971.
7. Byfield JE, Calabro-Jones P, Klisak I, et al: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys 8: 1923-1933, 1982.
8. Smalley SR, Kimler BF and Evans RG: 5-fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 20: 207-211, 1991.
9. Weinberg MJ and Rauth AM: 5-fluorouracil infusion and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 13: 1691-1699, 1987.
10. Bruso CE, Shewach DS and Lawrence TS: Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int J Radiat Oncol Biol Phys 19: 1411-1417, 1990.
11. Miller EM and Kinsella TJ: Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res 52: 1687-1694, 1992.
12. McGinn CJ and Kinsella TJ: The clinical rationale for S-phase radiosensitization in human tumors. Curr Probl Cancer 17: 273-321, 1993.
13. McGinn CJ, Miller EM, Lindstrom MJ, et al: The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int J Radiat Oncol Biol Phys 30: 851-859, 1994.
14. Cunningham D, Zalcberg J, Rath U, et al: 'Tomudex' (ZD1694): results of a randomized trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. Eur J Cancer 31A: 1945-1954, 1995.
15. Cunningham D, Zalcberg J, Rath U, et al: Final results of a randomized trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. 'Tomudex' Colorectal Cancer Study Group. Ann Oncol 7: 961-965, 1996.
16. Smith I, Jones A, Spielmann M, et al: A phase II study in advanced breast cancer: ZD1694 (Tomudex) a novel direct and specific thymidylate synthase inhibitor. Br J Cancer 74: 479-481, 1996.
17. Teper J, Bernard S: Adjuvant therapy of rectal cancer. Oncology 6: 83-95, 1992.